Pluri Inc. Files Q1 2025 10-Q Report
Ticker: PLUR · Form: 10-Q · Filed: May 13, 2025 · CIK: 1158780
| Field | Detail |
|---|---|
| Company | Pluri Inc. (PLUR) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Pluri Inc. filed its 10-Q for Q1 2025. Financials and operations update.
AI Summary
Pluri Inc. filed its 10-Q report for the quarterly period ended March 31, 2025. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in Nevada and operates in the biological products sector. Its business address is located in Haifa, Israel.
Why It Matters
This filing provides investors with an update on Pluri Inc.'s financial performance and operational status for the first quarter of 2025.
Risk Assessment
Risk Level: low — This is a routine filing providing standard financial and operational information.
Key Players & Entities
- Pluri Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- Pluristem Therapeutics Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Haifa, Israel (location) — Business address
FAQ
What is the filing date of this 10-Q report?
The filing date of this 10-Q report is May 13, 2025.
What is the reporting period for this 10-Q?
The reporting period for this 10-Q is the quarterly period ended March 31, 2025.
What was Pluri Inc. previously named?
Pluri Inc. was formerly named Pluristem Therapeutics Inc. and Pluristem Life Systems Inc.
In which state is Pluri Inc. incorporated?
Pluri Inc. is incorporated in Nevada.
Where is Pluri Inc.'s business address located?
Pluri Inc.'s business address is located at MATAM Advanced Technology Park, Building No. 5, Haifa, Israel.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Pluri Inc. (PLUR).